Abbott Laboratories: 10-K Risk Factor Changes

2024 vs 2023  ·  SEC EDGAR  ·  2026-05-22
Other years: 2026 vs 2025 · 2025 vs 2024
⚠ AI-Generated

The summary below was generated by an AI language model and may contain errors or omissions. All other content on this page is deterministically extracted from the original SEC EDGAR filing.

Abbott added a new tax risk disclosure addressing potential adverse changes in tax laws and regulations globally that could impact its effective tax rate and financial condition. The company substantively modified its public health crisis risk factor, likely reflecting lessons from COVID-19's material business impact, alongside updates to competitive and regulatory compliance risks. These changes represent a net addition of one risk disclosure with five substantive modifications across existing risk factors.

✓ Deterministic extraction — no AI-generated data

Classification is based on semantic text similarity scoring and may include approximations. “No match” means no high-confidence textual match was found — not necessarily that a section was removed.

1
New Risks
0
Removed
5
Modified
15
Unchanged
🟢 New in Current Filing Adverse changes in tax laws, regulations and interpretations, both in the U.S. and internationally, could have a material adverse effect on Abbott’s effective tax rate, financial condition and results of operations. 🔒
🟡 Modified Abbott is subject to risks related to public health crises, such as widespread outbreaks of infectious diseases like the COVID-19 pandemic, which had a material effect on Abbott’s business, financial condition and results of operations. 🔒
🟡 Modified New products and technological advances by Abbott’s competitors may negatively affect Abbott’s results of operations. 🔒
🟡 Modified It is costly for Abbott to comply with numerous governmental regulations and to develop compliant products and processes, and consequences for non-compliance could have a material adverse effect on Abbott's revenues, profitability, cash flows, and financial condition. 🔒
🟡 Modified Disruptions to Abbott’s global supply chain, which is large and complex, could negatively affect Abbott’s results of operations. 🔒
🟡 Modified Abbott depends on sophisticated information systems and maintains protected personal data, and a significant cybersecurity incident or other disruption affecting these information systems or protected data could have a material adverse effect on Abbott’s business, financial condition and results of operations. 🔒
6 changes in this historical filing

Historical year-over-year comparisons (2024 vs 2023 and earlier) are available on the Pro plan.

Get full access — from $29/month Already a Pro subscriber? View full diff →